Try our mobile app
Screener

Reviews

2026-11-13
#reports #TAL
@ china , @ edtech

[TAL Education](https://eninvs.com/all.php?name=TAL) (Educational service provider) reported for 2026 q3
(2026-04-23, Before Market Open):

- Revenue -7.1% YoY (vs -9.0% in previous quarter and historical rate -6.0%)
- EBITDA -72.2% YoY (vs -52.4% in previous quarter)
- EBITDA margin 7.7% decreased compared to 25.7% same period last year
- Net Debt decreased by $13 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 89.1x compared to historical level (75th percentile) of 646x
- EV/Sales multiple is 24.6x

2026-11-13
#reports #YETI

[YETI](https://eninvs.com/all.php?name=YETI) (Goods for outdoor activities manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204311)
(2026-05-14, Before Market Open):

- Revenue +4.3% YoY (vs +8.5% in previous quarter and historical rate +8.4%)
- EBITDA +11.8% YoY (vs +44.0% in previous quarter and historical rate +32.4%)
- EBITDA margin 14.9% increased compared to 13.9% same period last year
- Net Debt decreased by $43 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.5x

2026-11-13
#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204302)
(2026-03-12, Before Market Open):

- Revenue -29.4% YoY (vs +12.0% in previous quarter and historical rate +11.0%)
- EBITDA margin -238.6% decreased compared to -52.2% same period last year
- Net Debt increased by $662 mln over the past reporting period (17019.4% of market cap)
- FCF (LTM) +$2.4 bln (positive), 60416.3% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 7.4x
- EV/Sales multiple is -2x

2026-11-13
#reports #WWW

[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204269)
(2026-05-14, Before Market Open):

- Revenue +7.4% YoY (vs +6.8% in previous quarter and historical rate -4.4%)
- EBITDA +76.7% YoY (vs +9.4% in previous quarter and historical rate +38.9%)
- EBITDA margin 21.0% increased compared to 12.8% same period last year
- Net Debt decreased by $50 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 8.0% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.2x

2026-11-13
#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for 2026 q3
(2026-05-15, Before Market Open):

- Revenue +40% YoY (vs -60.0% in previous quarter and historical rate -18.0%)
- EBITDA margin -128.6% decreased compared to 0.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 2.0% of market cap
- EV/Sales multiple is 7.4x

2026-11-13
#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204382)
(2026-05-15, After Market Close):

- Revenue +157.4% YoY (vs -2.0% in previous quarter and historical rate +77.8%)
- EBITDA margin -195.5% increased compared to -774.0% same period last year
- Net Debt decreased by $3.1 bln since the start of the year (15879.8% of market cap)
- FCF (LTM) +$3.6 bln (positive), 18066.5% of market cap
- EV/Sales multiple is 1.8x

2026-11-13
#reports #TWST

[Twist Bioscience](https://eninvs.com/all.php?name=TWST) (Medical services provider) reported for 2026 q3
(2026-05-04, Before Market Open):

- Revenue +28.3% YoY (vs +22.9% in previous quarter and historical rate +23.5%)
- EBITDA margin -16.5% increased compared to -27.3% same period last year
- Net Debt decreased by $414 mln over the past reporting period (5.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.2% of market cap
- EV/Sales multiple is 14.5x

2026-11-13
#reports #TTEK

[Tetra Tech](https://eninvs.com/all.php?name=TTEK) (Consulting company) reported for 2026 q3
(2026-01-28, After Market Close):

- Revenue +0.5% YoY (vs -4.5% in previous quarter and historical rate +4.9%)
- EBITDA +10.2% YoY (vs -3.4% in previous quarter and historical rate +38.2%)
- EBITDA margin 16.2% increased compared to 14.7% same period last year
- Net Debt increased by $78 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.8% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 21.4x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +7.7%
2026-11-13
#reports #TACT

[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2026 q3
(2026-05-12, After Market Close):

- Revenue +7.7% YoY (vs 0.0% in previous quarter and historical rate -8.1%)
- Net Debt decreased by $1 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) -$0 bln (negative), 2.0% of market cap
- EV/EBITDA multiple is 33.4x compared to historical level (75th percentile) of 32x
- EV/Sales multiple is 0.6x

2026-11-13
#reports #SSTI

[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204283)
(2026-05-14, After Market Close):

- Revenue 0% YoY (vs -7.7% in previous quarter and historical rate -3.2%)
- EBITDA margin -28.0% decreased compared to -8.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0 bln (negative), 4.6% of market cap
- EV/Sales multiple is 1.1x

2026-11-13
#reports #SRTS

[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue -14.3% YoY (vs -71.4% in previous quarter and historical rate +10.3%)
- EBITDA margin -16.7% increased compared to -28.6% same period last year
- EV/Sales multiple is 2.2x

2026-11-13
#reports #SPB

[Spectrum Brands](https://eninvs.com/all.php?name=SPB) (Consumer goods manufacturer) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue -7.9% YoY (vs -3.3% in previous quarter and historical rate +4.9%)
- EBITDA -51% YoY (vs -80.7% in previous quarter and historical rate +2.9%)
- EBITDA margin 3.4% decreased compared to 6.3% same period last year
- Net Debt decreased by $69 mln over the past reporting period (3.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 22.7x compared to historical level (75th percentile) of 20.9x
- EV/Sales multiple is 0.9x

2026-11-13
#reports #SMSI

[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204386)
(2026-03-04, After Market Close):

- Revenue +25% YoY (vs 0.0% in previous quarter and historical rate -23.7%)
- EV/Sales multiple is 0.9x

2026-11-13
#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204292)
(2026-03-26, After Market Close):

- Revenue +100% YoY (vs 0.0% in previous quarter and historical rate 0.0%)
- EBITDA margin -50.0% increased compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (74.3% of market cap)
- FCF (LTM) -$0 bln (negative), 148.5% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is -0.3x

2026-11-13
#reports #OPHC

[OptimumBank](https://eninvs.com/all.php?name=OPHC) (Banks — Regional) reported for 2026 q3
(2026-02-02, Before Market Open):

- Revenue +13.3% YoY (vs -6.3% in previous quarter and historical rate +67.4%)
- Net Income margin 52.9% increased compared to 0.0% same period last year
- P/E multiple is 8.3x compared to historical level (75th percentile) of 3.8x
- P/S multiple is 3.8x
- Price to book: 1.8x

At the opening of the session the share price went down -1.0%
2026-11-13
#reports #NUWE

[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204297)
(2026-03-11):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -100.0% increased compared to -150.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (220.5% of market cap)
- FCF (LTM) -$0 bln (negative), 220.5% of market cap
- EV/Sales multiple is 1.1x

2026-11-13
#reports #NSPR

[InspireMD](https://eninvs.com/all.php?name=NSPR) (Medical Devices) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue -33.3% YoY (vs 0.0% in previous quarter and historical rate +26.4%)
- EBITDA margin -500.0% decreased compared to -433.3% same period last year
- Net Debt decreased by $35 mln over the past reporting period (97.3% of market cap)
- FCF (LTM) -$0 bln (negative), 136.2% of market cap
- EV/EBITDA multiple is 0.5x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is -2.7x

2026-11-13
#reports #MGTX

[MeiraGTx](https://eninvs.com/all.php?name=MGTX) (Biotechnology) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204326)
(2026-05-14, Before Market Open):

- Revenue -64.3% YoY (vs +120.0% in previous quarter and historical rate +6.2%)
- EBITDA margin -940.0% decreased compared to -407.1% same period last year
- Net Debt decreased by $15 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/Sales multiple is 47.1x

2026-11-13
#reports #INVE

[Identiv](https://eninvs.com/all.php?name=INVE) (Computer Hardware) reported for 2026 q3
(2026-05-13, After Market Close):

- Revenue -40% YoY (vs +20.0% in previous quarter and historical rate -31.2%)
- EBITDA margin -266.7% decreased compared to -100.0% same period last year
- Net Debt increased by $32 mln over the past reporting period (49.5% of market cap)
- FCF (LTM) -$0 bln (negative), 9.3% of market cap
- EV/EBITDA multiple is 1.1x compared to historical level (75th percentile) of 2.9x
- EV/Sales multiple is -1x

2026-11-13
#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for 2026 q3
(2026-03-24, After Market Close):

- Revenue +50% YoY (vs -50.0% in previous quarter and historical rate +25.0%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- EV/Sales multiple is 3.2x

2026-11-13
#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2026 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=204264)
(2026-05-12, After Market Close):

- Revenue 0% YoY (vs +20.0% in previous quarter and historical rate +24.9%)
- Net Debt decreased by $2 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 8.8% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 112x
- EV/Sales multiple is 0.9x